Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
18.87
+2.25 (13.54%)
Nov 22, 2024, 4:00 PM EST - Market closed
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $479.58 million as of November 22, 2024. Its market cap has increased by 194.94% in one year.
Market Cap
479.58M
Enterprise Value
275.03M
1-Year Change
194.94%
Ranking
Category
Stock Price
$18.87
Market Cap Chart
Since June 22, 2016, Cartesian Therapeutics's market cap has increased from $236.80M to $479.58M, an increase of 102.52%. That is a compound annual growth rate of 8.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 430.50M | 302.34% |
| Dec 29, 2023 | 107.00M | -38.11% |
| Dec 30, 2022 | 172.90M | -54.54% |
| Dec 31, 2021 | 380.30M | 16.19% |
| Dec 31, 2020 | 327.30M | 185.35% |
| Dec 31, 2019 | 114.70M | 92.13% |
| Dec 31, 2018 | 59.70M | -72.75% |
| Dec 29, 2017 | 219.10M | -29.78% |
| Dec 30, 2016 | 312.00M | 31.76% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| National Research | 456.02M |
| Y-mAbs Therapeutics | 455.06M |
| Arcturus Therapeutics Holdings | 450.19M |
| Aura Biosciences | 449.14M |
| Sonida Senior Living | 448.41M |
| Acelyrin | 443.44M |
| DocGo | 437.80M |
| Foghorn Therapeutics | 437.52M |